Mikhail V. Keniya

2.2k total citations · 1 hit paper
30 papers, 1.7k citations indexed

About

Mikhail V. Keniya is a scholar working on Infectious Diseases, Epidemiology and Organic Chemistry. According to data from OpenAlex, Mikhail V. Keniya has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Organic Chemistry. Recurrent topics in Mikhail V. Keniya's work include Antifungal resistance and susceptibility (26 papers), Fungal Infections and Studies (9 papers) and Peptidase Inhibition and Analysis (7 papers). Mikhail V. Keniya is often cited by papers focused on Antifungal resistance and susceptibility (26 papers), Fungal Infections and Studies (9 papers) and Peptidase Inhibition and Analysis (7 papers). Mikhail V. Keniya collaborates with scholars based in New Zealand, United States and Austria. Mikhail V. Keniya's co-authors include Brian C. Monk, Richard D. Cannon, Joel D. A. Tyndall, A. Sagatova, Rajni K. Wilson, Ann R. Holmes, Erwin Lamping, Masakazu Niimi, Koichi Tanabe and Kyoko Niimi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Microbiology Reviews.

In The Last Decade

Mikhail V. Keniya

28 papers receiving 1.6k citations

Hit Papers

Efflux-Mediated Antifungal Drug Resistance 2009 2026 2014 2020 2009 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efflux-Mediated Antifungal Drug Resistance
    2009 456 citations Richard D. Cannon, Erwin Lamping et al. Clinical Microbiology Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikhail V. Keniya New Zealand 16 959 597 479 399 251 30 1.7k
Erwin Lamping New Zealand 20 1.2k 1.3× 875 1.5× 745 1.6× 273 0.7× 185 0.7× 44 2.1k
Lan Yan China 25 846 0.9× 496 0.8× 654 1.4× 277 0.7× 274 1.1× 82 1.9k
Ed T. Buurman United States 23 532 0.6× 438 0.7× 1.1k 2.2× 247 0.6× 114 0.5× 46 1.8k
Sanjib Bhakta United Kingdom 33 1.1k 1.2× 666 1.1× 1.3k 2.7× 548 1.4× 231 0.9× 100 2.7k
Sudagar S. Gurcha United Kingdom 32 1.2k 1.3× 1.0k 1.7× 1.6k 3.3× 789 2.0× 216 0.9× 61 3.1k
Patrick Marichal Belgium 27 1.5k 1.5× 1.1k 1.8× 699 1.5× 342 0.9× 404 1.6× 38 2.6k
Norman C. Waters United States 33 438 0.5× 339 0.6× 902 1.9× 457 1.1× 142 0.6× 84 2.8k
L A Collins United States 13 971 1.0× 685 1.1× 880 1.8× 658 1.6× 252 1.0× 15 2.3k
Kyung‐Ae Lee South Korea 23 563 0.6× 273 0.5× 544 1.1× 227 0.6× 135 0.5× 55 1.9k
Ashok K. Chaturvedi United States 19 876 0.9× 614 1.0× 483 1.0× 397 1.0× 110 0.4× 34 1.6k

Countries citing papers authored by Mikhail V. Keniya

Since Specialization
Citations

This map shows the geographic impact of Mikhail V. Keniya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail V. Keniya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail V. Keniya more than expected).

Fields of papers citing papers by Mikhail V. Keniya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail V. Keniya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail V. Keniya. The network helps show where Mikhail V. Keniya may publish in the future.

Co-authorship network of co-authors of Mikhail V. Keniya

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail V. Keniya. A scholar is included among the top collaborators of Mikhail V. Keniya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail V. Keniya. Mikhail V. Keniya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tatar, Esra, Diane Kelly, Steven L. Kelly, et al.. (2025). Exploring medium and long arm extensions of 1,2,4-triazole derivatives as Candida albicans 14α-demethylase (CYP51) inhibitors. RSC Medicinal Chemistry. 16(5). 2270–2280.
2.
Keniya, Mikhail V., Christoph Müller, Bettina Sarg, et al.. (2025). Intrinsic resistance to short-tailed azoles in the basal fungus Mucor lusitanicus: functional analysis of Cyp51 isoforms and amino acid substitutions. Frontiers in Microbiology. 16. 1702408–1702408. 1 indexed citations
3.
Keniya, Mikhail V., Carmel Hughes, Arwyn T. Jones, et al.. (2025). Exploring Long Arm Amide-Linked Side Chains in the Design of Antifungal Azole Inhibitors of Sterol 14α-Demethylase (CYP51). Journal of Medicinal Chemistry. 68(11). 10781–10799. 1 indexed citations
4.
Lackner, Michaela, Mikhail V. Keniya, Carlos Lax, et al.. (2025). The molecular basis of intrinsic resistance to azoles in Rhizopus arrhizus. Antimicrobial Agents and Chemotherapy. 70(1). e0133725–e0133725. 1 indexed citations
5.
Keniya, Mikhail V., Ariel A. Aptekmann, Amir Arastehfar, et al.. (2025). Expression of 1,3-β-glucan synthase subunits in Candida glabrata is regulated by the cell cycle and growth conditions and at both transcriptional and post-transcriptional levels. Antimicrobial Agents and Chemotherapy. 69(8). e0050025–e0050025.
6.
Keniya, Mikhail V., A. Sagatova, Christoph Müller, et al.. (2024). The Molecular Basis of the Intrinsic and Acquired Resistance to Azole Antifungals in Aspergillus fumigatus. Journal of Fungi. 10(12). 820–820. 7 indexed citations
7.
Keniya, Mikhail V., et al.. (2024). Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit Candidozyma auris. Journal of Fungi. 10(10). 698–698. 5 indexed citations
8.
Aptekmann, Ariel A., Mikhail V. Keniya, Firat Kaya, et al.. (2024). Evolutionary dynamics in gut-colonizing Candida glabrata during caspofungin therapy: Emergence of clinically important mutations in sphingolipid biosynthesis. PLoS Pathogens. 20(9). e1012521–e1012521. 3 indexed citations
9.
10.
Lackner, Michaela, et al.. (2023). Clorgyline Analogs Synergize with Azoles against Drug Efflux in Candida auris. Journal of Fungi. 9(6). 663–663. 5 indexed citations
11.
Monk, Brian C., et al.. (2019). Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1868(3). 140206–140206. 90 indexed citations
12.
13.
14.
Tyndall, Joel D. A., A. Sagatova, Mikhail V. Keniya, et al.. (2016). Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals. PLoS ONE. 11(12). e0167485–e0167485. 50 indexed citations
15.
Sagatova, A., et al.. (2016). Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14α-demethylase. Scientific Reports. 6(1). 26213–26213. 86 indexed citations
16.
Keniya, Mikhail V., Edmond Fleischer, Anette Klinger, Richard D. Cannon, & Brian C. Monk. (2015). Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance. PLoS ONE. 10(5). e0126350–e0126350. 51 indexed citations
17.
Sagatova, A., Mikhail V. Keniya, Rajni K. Wilson, Brian C. Monk, & Joel D. A. Tyndall. (2015). Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase. Antimicrobial Agents and Chemotherapy. 59(8). 4982–4989. 160 indexed citations
18.
Monk, Brian C., Thomas Tomasiak, Mikhail V. Keniya, et al.. (2014). Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer. Proceedings of the National Academy of Sciences. 111(10). 3865–3870. 226 indexed citations
19.
Keniya, Mikhail V., Richard D. Cannon, Binh A. Nguyen, Joel D. A. Tyndall, & Brian C. Monk. (2013). Heterologous expression ofCandida albicansPma1p inSaccharomyces cerevisiae. FEMS Yeast Research. 13(3). 302–311. 7 indexed citations
20.
Cannon, Richard D., Erwin Lamping, Ann R. Holmes, et al.. (2009). Efflux-Mediated Antifungal Drug Resistance. Clinical Microbiology Reviews. 22(2). 291–321. 456 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erwin Lamping Breakdown of academic impact, for papers by Lan Yan Breakdown of academic impact, for papers by Ed T. Buurman Breakdown of academic impact, for papers by Sanjib Bhakta Breakdown of academic impact, for papers by Sudagar S. Gurcha Breakdown of academic impact, for papers by Patrick Marichal Breakdown of academic impact, for papers by Norman C. Waters Breakdown of academic impact, for papers by L A Collins Breakdown of academic impact, for papers by Kyung‐Ae Lee Breakdown of academic impact, for papers by Ashok K. Chaturvedi
Rankless by CCL
2026